Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
23.21
-0.99 (-4.09%)
Jan 8, 2026, 4:00 PM EST - Market closed
Ultragenyx Pharmaceutical Analyst Ratings
Total Analysts
20
Consensus Rating
Strong Buy
Price Target
$76.45
Upside
+229.38%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $80 → $60 | Strong Buy | Maintains | $80 → $60 | +158.51% | Jan 5, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $64 → $52 | Strong Buy | Maintains | $64 → $52 | +124.04% | Jan 5, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $72 → $58 | Strong Buy | Maintains | $72 → $58 | +149.89% | Jan 2, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $80 → $70 | Buy | Maintains | $80 → $70 | +201.59% | Dec 30, 2025 |
| Baird | Baird | Buy Maintains $72 → $47 | Buy | Maintains | $72 → $47 | +102.50% | Dec 30, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $65 → $45 | Buy | Maintains | $65 → $45 | +93.88% | Dec 30, 2025 |
| Jefferies | Jefferies | Strong Buy Maintains $114 → $63 | Strong Buy | Maintains | $114 → $63 | +171.43% | Dec 30, 2025 |
| Barclays | Barclays | Buy Maintains $81 → $50 | Buy | Maintains | $81 → $50 | +115.42% | Nov 24, 2025 |
| TD Cowen | TD Cowen | Strong Buy Maintains $86 → $75 | Strong Buy | Maintains | $86 → $75 | +223.14% | Nov 5, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $100 → $90 | Strong Buy | Maintains | $100 → $90 | +287.76% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +244.68% | Sep 9, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $105 | Buy | Reiterates | $105 | +352.39% | Sep 5, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $136 → $128 | Strong Buy | Maintains | $136 → $128 | +451.49% | Aug 8, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $112 → $105 | Buy | Maintains | $112 → $105 | +352.39% | Aug 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $80 | Strong Buy | Initiates | $80 | +244.68% | Jul 28, 2025 |
| Wedbush | Wedbush | Hold Maintains $35 → $34 | Hold | Maintains | $35 → $34 | +46.49% | Jul 14, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.